drugset / Trial / NCT00212056

Japan-Working Groups of Acute Myocardial Infarction for the Reduction of Necrotic Damage by ANP

NCT00212056 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

To evaluate whether ANP as an adjunctive therapy for AMI reduces myocardial infarct size and improves regional wall motion.

Timeline

Start
2001-10
Primary completion
—
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator ANP Peptide 0.025 ug/kg Intravenous